Bristol Myers Squibb (BMY) Cash & Current Investments (2009 - 2026)
Bristol Myers Squibb (BMY) reported Cash & Current Investments of $10.5 billion for Q1 2026, down 11.0% year-over-year from $11.8 billion in Q1 2025, and down 1.75% on a QoQ basis from $10.7 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Cash & Current Investments data on file, last reported at $10.5 billion in Q1 2026.
- Quarterly Cash & Current Investments fell 11.0% year-over-year to $10.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 billion (down 11.0% YoY) and the FY2025 annual result came in at $10.7 billion, down 1.71% from the prior year.
- Cash & Current Investments slipped to $10.5 billion in Q1 2026 per BMY's latest filing, from $10.7 billion in the prior quarter.
- Across five years, Cash & Current Investments topped out at $16.5 billion in Q3 2025 and bottomed at $6.7 billion in Q2 2024.
- The 5-year median for Cash & Current Investments is $10.5 billion (2026), against an average of $10.8 billion.
- The widest annual swing landed in 2022, when Cash & Current Investments plunged 45.46%; it then soared 104.46% in 2025.
- Tracing BMY's Cash & Current Investments over 5 years: stood at $9.3 billion in 2022, then soared by 32.71% to $12.3 billion in 2023, then retreated by 11.57% to $10.9 billion in 2024, then slipped by 1.71% to $10.7 billion in 2025, then slipped by 1.75% to $10.5 billion in 2026.
- Per Business Quant, the three latest BMY Cash & Current Investments figures stand at $10.5 billion (Q1 2026), $10.7 billion (Q4 2025), and $16.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 9.39 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 5.70 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 7.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 13.08 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 10.49 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.49 Bn |
| Dec 31, 2025 | 10.67 Bn |
| Sep 30, 2025 | 16.50 Bn |
| Jun 30, 2025 | 13.60 Bn |
| Mar 31, 2025 | 11.78 Bn |
| Dec 31, 2024 | 10.86 Bn |
| Sep 30, 2024 | 8.09 Bn |
| Jun 30, 2024 | 6.65 Bn |
| Mar 31, 2024 | 9.67 Bn |
| Dec 31, 2023 | 12.28 Bn |
| Sep 30, 2023 | 7.69 Bn |
| Jun 30, 2023 | 8.73 Bn |
| Mar 31, 2023 | 9.27 Bn |
| Dec 31, 2022 | 9.25 Bn |
| Sep 30, 2022 | 9.03 Bn |
| Jun 30, 2022 | 13.23 Bn |
| Mar 31, 2022 | 14.97 Bn |
| Dec 31, 2021 | 16.97 Bn |
| Sep 30, 2021 | 15.66 Bn |
| Jun 30, 2021 | 12.97 Bn |
| Mar 31, 2021 | 12.93 Bn |
| Dec 31, 2020 | 15.83 Bn |
| Sep 30, 2020 | 21.16 Bn |
| Jun 30, 2020 | 21.66 Bn |
| Mar 31, 2020 | 18.32 Bn |
| Dec 31, 2019 | 15.39 Bn |
| Sep 30, 2019 | 32.54 Bn |
| Jun 30, 2019 | 29.36 Bn |
| Mar 31, 2019 | 8.76 Bn |
| Dec 31, 2018 | 8.76 Bn |
| Sep 30, 2018 | 6.83 Bn |
| Jun 30, 2018 | 6.08 Bn |
| Mar 31, 2018 | 6.77 Bn |
| Dec 31, 2017 | 10.84 Bn |
| Sep 30, 2017 | 7.12 Bn |
| Jun 30, 2017 | 6.51 Bn |
| Mar 31, 2017 | 6.11 Bn |
| Dec 31, 2016 | 6.35 Bn |
| Sep 30, 2016 | 5.56 Bn |
| Jun 30, 2016 | 4.65 Bn |
| Mar 31, 2016 | 4.31 Bn |
| Dec 31, 2015 | 4.27 Bn |
| Sep 30, 2015 | 5.41 Bn |
| Jun 30, 2015 | 5.48 Bn |
| Mar 31, 2015 | 7.61 Bn |
| Dec 31, 2014 | 7.44 Bn |
| Sep 30, 2014 | 7.22 Bn |
| Jun 30, 2014 | 7.18 Bn |
| Mar 31, 2014 | 7.06 Bn |
| Dec 31, 2013 | 4.53 Bn |
| Sep 30, 2013 | 2.72 Bn |
| Jun 30, 2013 | 2.80 Bn |
| Mar 31, 2013 | 2.53 Bn |
| Dec 31, 2012 | 2.83 Bn |
| Sep 30, 2012 | 2.93 Bn |
| Jun 30, 2012 | 5.04 Bn |
| Mar 31, 2012 | 5.03 Bn |
| Dec 31, 2011 | 8.73 Bn |
| Sep 30, 2011 | 8.19 Bn |
| Jun 30, 2011 | 7.67 Bn |
| Mar 31, 2011 | 6.79 Bn |
| Dec 31, 2010 | 7.30 Bn |
| Sep 30, 2010 | 11.28 Bn |
| Jun 30, 2010 | 9.51 Bn |
| Mar 31, 2010 | 8.02 Bn |
| Dec 31, 2009 | 8.51 Bn |
| Sep 30, 2009 | 8.69 Bn |
| Jun 30, 2009 | 9.42 Bn |
| Mar 31, 2009 | 870.00 Mn |